Evidence map›Paper›PMID 28935638›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2018

Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK.

Michael P Mohning, Stacey M Thomas, Lea Barthel, Kara J Mould, Alexandria L McCubbrey, S Courtney Frasch, Donna L Bratton, Peter M Henson, William J Janssen

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Recent advances in TAM mechanisms in lung diseases.Journal of translational medicine · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. HLA-DRB1*15:01 and theNeurology(R) neuroimmunology & neuroinflammation · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Michael P MohningDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health , Denver, Colorado.ORCID 0000-0003-3102-8762
Stacey M ThomasDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health , Denver, Colorado.
Lea BarthelDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health , Denver, Colorado.
Kara J MouldDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Colorado-Anschutz Medical Campus , Aurora, Colorado.
Alexandria L McCubbreyDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health , Denver, Colorado.ORCID 0000-0002-2049-9609
S Courtney FraschDepartment of Pediatrics, National Jewish Health , Denver, Colorado.
Donna L BrattonDepartment of Pediatrics, National Jewish Health , Denver, Colorado.
Peter M HensonDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Colorado-Anschutz Medical Campus , Aurora, Colorado.
William J JanssenDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health , Denver, Colorado.
National Jewish Health · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Macrophage Apoptosis in Resolution of Acute Lung InjuryR01HL109517 · NHLBI · NATIONAL JEWISH HEALTH · PI JANSSEN, WILLIAM · 2012 to 2017
$3.1M
Macrophage endocytosis in resolving lung inflammationR01HL114381 · NHLBI · NATIONAL JEWISH HEALTH · PI HENSON, PETER M · 2013 to 2016
$2.6M
Reversal of Inflammatory Processes in CGDR01AI110408 · NIAID · NATIONAL JEWISH HEALTH · PI BRATTON, DONNA L · 2014 to 2018
$2.0M
NHLBI NIH HHS R01 HL109517NHLBI NIH HHS R01 HL114381NIAID NIH HHS R01 AI110408
6 · The paper itself

Abstract

Microparticles are a newly recognized class of mediators in the pathophysiology of lung inflammation and injury, but little is known about the factors that regulate their accumulation and clearance. The primary objective of our study was to determine whether alveolar macrophages engulf microparticles and to elucidate the mechanisms by which this occurs. Alveolar microparticles were quantified in bronchoalveolar fluid of mice with lung injury induced by LPS and hydrochloric acid. Microparticle numbers were greatest at the peak of inflammation and declined as inflammation resolved. Isolated, fluorescently labeled particles were placed in culture with macrophages to evaluate ingestion in the presence of endocytosis inhibitors. Ingestion was blocked with cytochalasin D and wortmannin, consistent with a phagocytic process. In separate experiments, mice were treated intratracheally with labeled microparticles, and their uptake was assessed though microscopy and flow cytometry. Resident alveolar macrophages, not recruited macrophages, were the primary cell-ingesting microparticles in the alveolus during lung injury. In vitro, microparticles promoted inflammatory signaling in LPS primed epithelial cells, signifying the importance of microparticle clearance in resolving lung injury. Microparticles were found to have phosphatidylserine exposed on their surfaces. Accordingly, we measured expression of phosphatidylserine receptors on macrophages and found high expression of MerTK and Axl in the resident macrophage population. Endocytosis of microparticles was markedly reduced in MerTK-deficient macrophages in vitro and in vivo. In conclusion, microparticles are released during acute lung injury and peak in number at the height of inflammation. Resident alveolar macrophages efficiently clear these microparticles through MerTK-mediated phagocytosis.

Indexed as

PhagocytosisAcute Lung InjuryAnimalsApoptosisAxl Receptor Tyrosine KinaseCell-Derived Microparticlesc-Mer Tyrosine KinaseInflammationMacrophages, AlveolarMaleMiceMice, Inbred C57BLMice, KnockoutProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesSignal TransductionAxl Receptor Tyrosine KinaseAXL receptor tyrosine kinase, mousec-Mer Tyrosine KinaseMertk protein, mouseProto-Oncogene ProteinsReceptor Protein-Tyrosine Kinasesalveolar macrophagelung injuryMer tyrosine kinasemicroparticlephagocytosis

Identifiers

PMID28935638
PMCPMC6335009
OpenAlexW2757837045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.